Tata India Pharma & Healthcare Fund - Direct (G)


Sectoral / Thematic
  • NAV 35.66 (-0.98%)
  • Fund Size (Cr) ₹1208.25
  • Expense Ratio 0.7
  • Scheme Type Active Fund
  • Value Research Stars
  • Minimum investment ₹5000
  • Minimum Additional Investment ₹1000
  • Minimum SIP Investment ₹100
  • Minimum Withdrawal ₹500
  • Exit Load 0.25%
  • Return Since Launch 15.66%

Basic Details

Scheme Manager
Meeta Shetty
Bench Mark
Nifty Pharma TRI
Type
OPEN

Lumpsum Returns

  • Period Invested For
  • ₹10000 Invested on
  • Latest Value
  • Absolute Returns
  • Annualised Returns
  • Category Avg
  • Rank within Category
  • 1 Week
  • 09-Oct-24
  • 9916.87
  • -0.83%
  • -
  • 0.60%
  • 707/758
  • 1 Month
  • 16-Sep-24
  • 9955.22
  • -0.45%
  • -
  • -0.35%
  • 378/745
  • 3 Month
  • 16-Jul-24
  • 11407.29
  • 14.07%
  • -
  • 4.31%
  • 40/713
  • 6 Month
  • 16-Apr-24
  • 12633.60
  • 26.34%
  • -
  • 19.73%
  • 101/668
  • 1 Year
  • 16-Oct-23
  • 15756.62
  • 57.57%
  • 57.57%
  • 43.36%
  • 80/600
  • 3 Year
  • 14-Oct-21
  • 18192.37
  • 81.92%
  • 22.08%
  • 19.17%
  • 153/460
  • 5 Year
  • 16-Oct-19
  • 38503.49
  • 285.03%
  • 30.95%
  • 24.44%
  • 70/380
  • Since Inception
  • 28-Dec-15
  • 36012.70
  • 260.13%
  • 15.66%
  • 21.76%
  • 522/760

Note: Lumpsum Returns since Inception Date.

SIP Returns

  • Period Invested For
  • ₹10000 Invested on
  • Investments
  • Latest Value
  • Absolute Returns
  • Annualised Returns
  • 1 Year
  • 01-Nov-23
  • 120000
  • 149703.54
  • 24.75%
  • 24.75%
  • 3 Year
  • 01-Nov-21
  • 360000
  • 600140.97
  • 66.71%
  • 18.57%
  • 5 Year
  • 01-Nov-19
  • 600000
  • 1231971.47
  • 105.33%
  • 15.48%
  • 10 Year
  • -
  • -
  • -
  • -
  • -

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

  • Investment Type

  • Monthly Investment

  • Expected Returns Rate

    %
  • Time Period

    yrs

Total of your Investment will be

0

70%
Returns
  • Invested Amount

    0
  • Estimated Returns

    0
Why Wait? Start Investing
  • Select Scheme

  • Investment Type

  • Monthly Investment

  • Time Period


Total of your Investment will be

0

70%
Returns
  • Invested Amount

    0
  • Estimated Returns

    0
* The calculator shows annualized returns.
Why Wait? Start Investing

Risk Ratios

  • Standard Deviation
    4.43%
  • Beta
    0.92%
  • Sharpe Ratio
    0.95%
  • Treynor’s Ratio
    0.41%
  • Jension’s Alpha
    4.27%

Asset Allocation

There is no Asset Allocation data.

Sector Allocation

There is no Sector Allocation data.

Top 10 stock holding in portfolio

  • Stock Invested in
  • % of Total Holdings
  • Quantity
  • Value (Cr)
  • Asset Type
  • Segment
  • Sun Pharma.Inds.
  • 12.83%
  • 804300
  • 154.96
  • Equity
  • Pharmaceuticals
  • Aurobindo Pharma
  • 8.96%
  • 741000
  • 108.24
  • Equity
  • Pharmaceuticals
  • Lupin
  • 7.44%
  • 410240
  • 89.89
  • Equity
  • Pharmaceuticals
  • Dr Reddy's Labs
  • 6.87%
  • 122911
  • 82.98
  • Equity
  • Pharmaceuticals
  • Cipla
  • 6.71%
  • 490000
  • 81.05
  • Equity
  • Pharmaceuticals
  • Divi's Lab.
  • 4.73%
  • 104965
  • 57.14
  • Equity
  • Pharmaceuticals
  • Fortis Health.
  • 4.35%
  • 855100
  • 52.60
  • Equity
  • Healthcare
  • Zydus Lifesci.
  • 4.17%
  • 471287
  • 50.36
  • Equity
  • Pharmaceuticals
  • Alkem Lab
  • 3.77%
  • 75249
  • 45.55
  • Equity
  • Pharmaceuticals
  • Apollo Hospitals
  • 3.51%
  • 58903
  • 42.41
  • Equity
  • Healthcare

Peer Comparison

  • Scheme Name
  • Value Research
  • Asset Size (Cr)
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • Tata India Pharma & Healthcare Fund - Direct (G)
  • Stars
  • 1208.25
  • -0.45%
  • 14.07%
  • 26.34%
  • 57.57%
  • 22.08%
  • HDFC Defence Fund - Direct (G)
  • Stars
  • 3996.82
  • 0.19%
  • -9.23%
  • 24.30%
  • 83.05%
  • -
  • HDFC Defence Fund - Direct (IDCW)
  • Stars
  • 3996.82
  • 0.19%
  • -9.23%
  • 24.30%
  • 83.05%
  • -
  • LIC MF Infrastructure Fund - Direct (G)
  • Stars
  • 750.04
  • 2.39%
  • 1.88%
  • 35.28%
  • 74.09%
  • 34.98%
  • LIC MF Infrastructure Fund - Direct (IDCW)
  • Stars
  • 750.04
  • 2.39%
  • 1.88%
  • 35.26%
  • 74.00%
  • 34.80%
  • Bandhan Infrastructure Fund - Direct (G)
  • Stars
  • 1905.92
  • -1.16%
  • -2.21%
  • 23.06%
  • 69.15%
  • 32.64%

News

  • Tata AMC launches Nifty Capital Markets Index fund Tata Mutual Fund has announced the launch of the Tata Nifty Capital Markets Index Fund, a new fund offer (NFO) that aims to provide investors with returns commensurate with the performance of the Nifty Capital Markets Index (TRI).

    The NFO for the fund is open for subscription from 7 October to 21 October 2024. The scheme will then reopen for continuous sale and repurchase on 30 October 2024.

    The fund will be managed by Kapil Menon. Investors can enter the fund with a minimum investment of Rs 5,000 during the NFO. An exit load of 0.25% will be applicable if units are redeemed within 15 days from allotment.

    The Tata Nifty Capital Markets Index Fund will hold a maximum of 20 stocks from the parent Nifty 500 Index, representing various capital market businesses including exchanges, depositories, stockbroking, and financial products distribution. The weight of each stock in the index is based on its free-float market capitalization.

    According to NSE data, the Nifty Capital Markets index delivered a return of 104.78% over the past year and a compounded annual growth rate (CAGR) of 34.80% over the past five years.

    The top constituents of the Nifty Capital Markets Index are BSE, HDFC Asset Management Company, Multi Commodity Exchange of India, Central Depository Services (India), and Computer Age Management Services, which together make up over 60% of the index's portfolio.

    Powered by Capital Market - Live News

  • Tata Equity P/E Fund announces Income Distribution cum Capital Withdrawal (IDCW) Tata Mutual Fund has announced 10 October 2024 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the IDCW option of Tata Equity P/E Fund. The amount of IDCW on the face value of Rs 10 per unit will be:

    Tata Equity P/E Fund - Regular Plan ' IDCW Trigger ' Option A (5%): Rs 1.74

    Tata Equity P/E Fund - Direct Plan ' IDCW Trigger ' Option A (5%): Rs 1.92

    Powered by Capital Market - Live News

  • Tata MF announces Income Distribution cum capital withdrawal (IDCW) under two schemes Tata Mutual Fund has announced 03 October 2024 as the record date for declaration of Income Distribution cum capital withdrawal (IDCW) under the monthly IDCW option and under the Periodic IDCW Periodic-Payout/Reinvestment) of following schemes. The amount of IDCW (Rs per unit) on the face value of Rs 10 per unit will be:

    Tata Hybrid Equity Fund ' Regular Plan & Direct Plan: 0.39 each.

    Tata Equity Savings Fund ' Regular Plan & Direct Plan: 0.058 each.

    Powered by Capital Market - Live News

Fund House Details & Investment Objective

  • Date of Incorporation 04-Dec-2015
  • Total AUM (Cr) ₹1208.25

Tata India Pharma & Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Tata Mutual Fund. Launched in Dec 2015, this fund is managed by Meeta Shetty. With assets under management (AUM) worth ₹1208.25 (Cr), as of 17-Oct-2024, Tata India Pharma & Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 15.66% since its launch.
The current NAV of Tata India Pharma & Healthcare Fund - Direct (G) is ₹35.66, as on 17-Oct-2024. The fund’s benchmark index is Nifty Pharma TRI. You can invest in Tata India Pharma & Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹5000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.
The fund has generated 22.08% and 30.95% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 93.75% in Equity, 0.29% in Debt and 5.96% in cash and cash equivalents
The top 5 sectors the fund invests in are: 75.42% in Pharmaceuticals & Biotech, 14.12% in Healthcare Services, 5.96% in Cash & Others, 2.29% in Insurance and 0.83% in Fertilisers & Agrochemica.

FAQs on Tata India Pharma & Healthcare Fund - Direct (G)

Tata India Pharma & Healthcare Fund - Direct (G) is a popular fund in the Sectoral / Thematic segment. The fund has generated a return of 15.66% since inception. Looking to invest in Tata India Pharma & Healthcare Fund - Direct (G)? How about earning 1% extra return? All this is possible with m.Stock! Investing in Tata India Pharma & Healthcare Fund - Direct (G) is super easy and convenient with m.Stock. Here’s how you can begin:

  • Login to your m.Stock account. If you do not have an account, open m.Stock Demat account and enjoy 1% extra returns plus Zero Brokerage across products for life.
  • In the ‘Menu’ section, under ‘Products’, select ‘Mutual Funds’ .
  • In the search bar, enter the fund name, in this case, Tata India Pharma & Healthcare Fund - Direct (G)
  • On the top right corner you’ll see two options – Lumpsum and SIP. You can choose either based on your risk appetite and available investible corpus.
  • If you choose to invest a Lumpsum: Enter amount, select payment mode (UPI or Netbanking), and click on ‘invest a lumpsum’. Make the payment and your lumpsum investment is complete.
  • If you choose the SIP route, then enter SIP amount, SIP date, and set up ‘Autopay’ facility.

So, why wait? Invest in Tata India Pharma & Healthcare Fund - Direct (G) today and reap the benefits of this Sectoral / Thematic fund!

In the short term, i.e., 1 year, Tata India Pharma & Healthcare Fund - Direct (G) has generated annualised return of 57.57%. In the long-term, the fund has generated 22.08% and 30.95% in 3 and 5 years respectively. Since its inception, the fund has generated 15.66% returns.

The expense ratio of Tata India Pharma & Healthcare Fund - Direct (G) Direct Growth is 0.7%. Expense ratio is the fees payable by investors of the scheme towards management, research and overall upkeep of the fund. The higher the expense ratio, the lower is the in-hand return for the investor. Expense ratio for direct plans is lower than regular plans, making them ideal for investors.

The Assets Under Management (AUM) of Tata India Pharma & Healthcare Fund - Direct (G) is ₹1208.25 (Cr) as of 17 October 2024. AUM shows the fund’s popularity and is often indicative of fund strength.

Redeeming or selling units of Tata India Pharma & Healthcare Fund - Direct (G) is relatively simple. But before you redeem, ensure that the fund has completed the minimum lock-in period else you will be charged an exit load.

To redeem from Tata India Pharma & Healthcare Fund - Direct (G):

  • Login to your m.Stock account
  • In portfolio, your mutual fund investments will be visible under ‘MF’
  • Select the fund you wish to redeem from (in this case Tata India Pharma & Healthcare Fund - Direct (G)).
  • Click on ‘Redeem’ button
  • You have 2 options – redeem by units and redeem by value (you can only redeem free units)
  • Select units to be redeemed and click on submit.
  • Redemption value will be credited to your account in 2-3 working days (as per timelines set by SEBI).

Yes, you can invest both lumpsum and SIP in Tata India Pharma & Healthcare Fund - Direct (G). Minimum lumpsum investment Tata India Pharma & Healthcare Fund - Direct (G) is ₹5000 and minimum SIP amount is ₹100. Lumpsum option is ideal for investors with higher investible corpus and market experience. SIP option is recommended for retail investors who do not have the time or expertise to time the market.

The latest NAV (Net Asset Value) of Tata India Pharma & Healthcare Fund - Direct (G) is ₹35.66 as on 17 October 2024.

The 5 biggest stock holdings of Tata India Pharma & Healthcare Fund - Direct (G) are:
Sun Pharma.Inds. (12.83%), Aurobindo Pharma (8.96%), Lupin (7.44%), Dr Reddy's Labs (6.87%), Cipla (6.71%)

A majority of Tata India Pharma & Healthcare Fund - Direct (G) 's AUM worth ₹1208.25 (Cr) is invested in these 3 top sectors:

  • Pharmaceuticals & Biotech: 75.42%
  • Healthcare Services: 14.12%
  • Cash & Others: 5.96%

Power your investments with our smart trading platforms

mobilefooterimg
  • app_download_icon_img
    10 million+
    App downloads
  • 1_Click_icon_img
    1-Click
    Order Placement
  • higherreturns_icon_img
    2,203 Crore+
    Average Daily Turnover